Summary
Medtronic plc filed an 8-K on August 22, 2023, to furnish its press release announcing its first quarter fiscal year 2024 financial results. While the filing itself doesn't contain the detailed financial performance data, it directs investors to the accompanying press release (Exhibit 99.1) for this crucial information. Investors should refer to that press release for specifics on revenue, earnings, segment performance, and any forward-looking guidance provided by the company for the first quarter of FY2024.
Key Highlights
- 1Medtronic plc filed an 8-K on August 22, 2023, reporting its Q1 FY2024 financial results.
- 2The 8-K filing serves to officially announce the release of its Q1 FY2024 earnings press release.
- 3Key financial details for Q1 FY2024 are contained within the press release furnished as Exhibit 99.1.
- 4Investors need to review the press release for performance metrics, including revenue and earnings.
- 5The filing includes the standard cover page interactive data file in Inline XBRL format.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and furnish Medtronic's press release detailing its financial results for the first quarter of fiscal year 2024.
The detailed financial results, including revenue, earnings, and other performance metrics for Q1 FY2024, are located in the press release that is attached as Exhibit 99.1 to this 8-K filing.
No, the 8-K filing primarily serves as a notification and an attachment point for the press release. The specific Q1 FY2024 financial numbers are within the press release (Exhibit 99.1), not directly in the body of the 8-K form itself.